By Dani Kass ( August 8, 2018, 6:45 PM EDT) -- The Federal Circuit on Wednesday affirmed the Patent Trial and Appeal Board's decision to invalidate several claims in a patent covering Alcon Laboratories' Durezol eye drops, shooting down an appeal from two Japanese drugmakers that were hoping to keep a generic version of the medication off the market....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.